Matza Louis S, Chung Karen, Van Brunt Kate, Brazier John E, Braun Ada, Currie Brooke, Palsgrove Andrew, Davies Evan, Body Jean-Jacques
Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD, 20814, USA,
Eur J Health Econ. 2014 Jan;15(1):7-18. doi: 10.1007/s10198-012-0443-2. Epub 2013 Jan 25.
Patients with bone metastases often experience skeletal-related events (SREs). Although cost-utility models are used to examine treatments for metastatic cancer, limited information is available on utilities of SREs. The purpose of this study was to estimate the disutility of four SREs: spinal cord compression, pathological fracture, radiation to bone, and surgery performed to stabilize a bone.
General population participants from the UK and Canada completed time trade-off (TTO) interviews to assess the utility of health states drafted based on literature review, clinician interviews, and patient interviews. Respondents first rated a health state describing cancer with bone metastases. Then, the SREs were added to this health state.
Interviews were completed with 187 participants (50.8 % male, 80.2 % white). Cancer with bone metastases without an SRE had a mean utility of 0.47 (SD = 0.43) on a standard utility scale (1 = full health, 0 = death). Of the SREs, spinal cord compression was associated with the greatest disutility (i.e., the utility decrease): -0.32 with paralysis and -0.22 without paralysis. Surgery had a disutility of -0.07. Leg, arm, and rib fractures had disutilities of -0.06, -0.04, and -0.03. Two weeks of daily radiation treatment had a disutility of -0.06, while two radiation appointments had the smallest impact on utility (-0.02).
All SREs were associated with statistically significant utility decreases, suggesting a perceived impact on quality of life beyond the impact of cancer with bone metastases. The resulting disutilities may be used in cost-utility models examining treatments to prevent SREs secondary to bone metastases.
骨转移患者常经历骨相关事件(SREs)。尽管成本效用模型用于研究转移性癌症的治疗方法,但关于SREs效用的信息有限。本研究的目的是评估四种SREs的负效用:脊髓压迫、病理性骨折、骨放疗以及为稳定骨骼而进行的手术。
来自英国和加拿大的普通人群参与者完成了时间权衡(TTO)访谈,以评估基于文献综述、临床医生访谈和患者访谈起草的健康状态的效用。受访者首先对描述伴有骨转移的癌症的健康状态进行评分。然后,将SREs添加到该健康状态中。
对187名参与者进行了访谈(男性占50.8%,白人占80.2%)。在标准效用量表(1 = 完全健康,0 = 死亡)上,无SREs的伴有骨转移的癌症的平均效用为0.47(标准差 = 0.43)。在SREs中,脊髓压迫与最大的负效用相关(即效用降低):瘫痪时为 -0.32,无瘫痪时为 -0.22。手术的负效用为 -0.07。腿部、手臂和肋骨骨折的负效用分别为 -0.06、-0.04和 -0.03。两周的每日放疗负效用为 -0.06,而两次放疗预约对效用的影响最小(-0.02)。
所有SREs均与统计学上显著的效用降低相关,表明其对生活质量的影响被认为超过了伴有骨转移的癌症的影响。由此产生的负效用可用于成本效用模型,以研究预防骨转移继发SREs的治疗方法。